Table 2 Participants of the RESULT study, conducted in Lilongwe Malawi and listed according to CKD stages as defined by K/DOQI [20] and HIV status
From: The prevalence of renal impairment in individuals seeking HIV testing in Urban Malawi
Kidney function (eGFR in ml/min/1.73 m2) | Total, n = 363 (%) | HIV-positive, n = 116 (%) | HIV-negative, n = 247 (%) |
|---|---|---|---|
Stage 0: No impairment: | |||
eGFR ≥ 60, − proteinuria | 316 (87) | 90 (77.6) | 226 (91.5) |
Stage 1: Kidney damage with normal or ↑GFR: | |||
eGFR ≥ 90 + proteinuria | 20 (5.5) | 8 (6.9) | 12 (4.9) |
Stage 2: Kidney damage with mild ↓ GFR: | |||
eGFR 60–89 + proteinuria | 16 (4.4) | 13 (11.2) | 3 (1.2) |
Stage 3: Moderate ↓ GFR: | |||
eGFR 30–59 ± proteinuria | 9 (2.5) | 5 (4.3) | 4 (1.6) |
Stage 4: Severe ↓ GFR: | |||
(eGFR 15–29 ± proteinuria) | 2 (0.6) | - | 2 (0.8) |